|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
178,600,000 |
Market
Cap: |
246.47(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.8901 - $1.85 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : 7.4 |
Insider 3/6 Months : 8 |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Precigen is a clinical-stage biopharmaceutical company improving gene and cell therapies. Co. is utilizing proprietary technology platforms to develop product candidates designed to diseases in its therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. Co. is developing its clinical programs, including: PRGN-3005, PRGN-3006, and PRGN-3007, which are built on its UltraCAR-T platform; PRGN-2009 and PRGN-2012, which are based on its AdenoVerse immunotherapy platform; and AG019, which is built on its ActoBiotics platform. In addition, Co. has completed a Phase 1 study of INXN-4001, a non-viral triple-effector plasmid DNA, which is built on its UltraVector platform.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
96,686 |
1,592,031 |
13,134,243 |
Total Buy Value |
$0 |
$136,327 |
$2,615,293 |
$22,822,494 |
Total People Bought |
0 |
1 |
4 |
8 |
Total Buy Transactions |
0 |
1 |
6 |
12 |
Total Shares Sold |
0 |
96,686 |
455,706 |
505,706 |
Total Sell Value |
$0 |
$136,327 |
$650,097 |
$765,097 |
Total People Sold |
0 |
1 |
6 |
6 |
Total Sell Transactions |
0 |
1 |
21 |
22 |
End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Bostick Thomas |
Chief Operating Officer |
|
2019-06-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,341 |
40,236 |
|
- |
|
Sterling Rick L. |
Chief Financial Officer |
|
2019-06-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,341 |
108,988 |
|
- |
|
Reed Thomas D. |
Chief Science Officer |
|
2019-06-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,341 |
110,621 |
|
- |
|
Lehr Donald P. |
Chief Legal Officer |
|
2019-06-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,341 |
62,298 |
|
- |
|
Walsh Robert F. Iii |
SVP, Energy & Fine Chem. |
|
2019-06-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,341 |
33,823 |
|
- |
|
Perez Jeffrey Thomas |
SVP, IP Affairs |
|
2019-06-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,341 |
46,904 |
|
- |
|
Kirk Randal J |
Chief Executive Officer |
|
2019-06-28 |
4 |
A |
$5.46 |
$999,942 |
I/I |
174,954 |
2,422,517 |
|
- |
|
Kirk Randal J |
Chief Executive Officer |
|
2019-06-07 |
4 |
B |
$5.26 |
$1,169,587 |
I/I |
222,355 |
157,413 |
2.64 |
- |
|
Kirk Randal J |
Chief Executive Officer |
|
2019-06-07 |
4 |
B |
$5.26 |
$779,727 |
I/I |
148,237 |
1,142,758 |
2.64 |
- |
|
Kirk Randal J |
Chief Executive Officer |
|
2019-06-06 |
4 |
B |
$5.23 |
$1,364,575 |
I/I |
260,913 |
156,212 |
2.64 |
- |
|
Kirk Randal J |
Chief Executive Officer |
|
2019-06-06 |
4 |
B |
$5.23 |
$909,717 |
I/I |
173,942 |
1,113,111 |
2.64 |
- |
|
Kirk Randal J |
Chief Executive Officer |
|
2019-06-04 |
4 |
B |
$5.17 |
$233,270 |
I/I |
45,120 |
1,078,323 |
2.64 |
- |
|
Kirk Randal J |
Chief Executive Officer |
|
2019-06-04 |
4 |
B |
$5.17 |
$349,900 |
I/I |
67,679 |
154,803 |
2.64 |
- |
|
Kirk Randal J |
Chief Executive Officer |
|
2019-06-03 |
4 |
A |
$4.33 |
$800,569 |
I/I |
184,889 |
2,276,030 |
|
- |
|
Kirk Randal J |
Chief Executive Officer |
|
2019-05-31 |
4 |
B |
$4.78 |
$432,246 |
I/I |
90,428 |
1,069,299 |
2.64 |
- |
|
Kirk Randal J |
Chief Executive Officer |
|
2019-05-31 |
4 |
B |
$4.78 |
$648,369 |
I/I |
135,642 |
154,438 |
2.64 |
- |
|
Kirk Randal J |
Chief Executive Officer |
|
2019-05-31 |
4 |
A |
$4.52 |
$200,159 |
I/I |
44,283 |
17,946,829 |
|
- |
|
Kirk Randal J |
Chief Executive Officer |
|
2019-05-30 |
4 |
B |
$4.79 |
$982,237 |
I/I |
205,060 |
1,051,213 |
2.64 |
- |
|
Kirk Randal J |
Chief Executive Officer |
|
2019-05-30 |
4 |
B |
$4.79 |
$1,473,366 |
I/I |
307,592 |
153,706 |
2.64 |
- |
|
Kirk Randal J |
Chief Executive Officer |
|
2019-05-29 |
4 |
B |
$4.68 |
$585,562 |
I/I |
125,120 |
1,010,201 |
2.64 |
- |
|
Kirk Randal J |
Chief Executive Officer |
|
2019-05-29 |
4 |
B |
$4.68 |
$878,338 |
I/I |
187,679 |
152,045 |
2.64 |
- |
|
Kirk Randal J |
Chief Executive Officer |
|
2019-05-24 |
4 |
B |
$4.68 |
$508,459 |
I/I |
108,645 |
151,032 |
2.64 |
- |
|
Kirk Randal J |
Chief Executive Officer |
|
2019-05-24 |
4 |
B |
$4.68 |
$338,972 |
I/I |
72,430 |
985,177 |
2.64 |
- |
|
Kirk Randal J |
Chief Executive Officer |
|
2019-05-23 |
4 |
B |
$4.67 |
$600,683 |
I/I |
128,626 |
150,445 |
2.64 |
- |
|
Kirk Randal J |
Chief Executive Officer |
|
2019-05-23 |
4 |
B |
$4.67 |
$400,453 |
I/I |
85,750 |
970,691 |
2.64 |
- |
|
689 Records found
|
|
Page 17 of 28 |
|
|